Articles in regional publications that pertain to a wide range of North Carolina-related topics.
Search Results
26 results
for "Pharmaceutical industry"
Currently viewing results 1 - 15
|
PAGE
OF 2
|
Next |
Record #:
24413
Author(s):
Abstract:
The North Carolina pharmaceutical industry is rapidly expanding its research and production facilities. This article presents the top pharmaceutical companies in North Carolina and how they are helping expand the business in the state.
Source:
Business North Carolina
(NoCar HF 5001 B8x), Vol. 4 Issue 11, November 1984,
p15-19, il
Periodical Website
Subject(s):
Record #:
26978
Author(s):
Abstract:
Burroughs Wellcome Company discovered that the drug AZT can prolong the lives of many people with AIDS, but at an annual cost of about ten-thousand dollars per patient. North Carolina has a share of the federal safety-net program to help AIDS patients who can’t afford AZT. Others who are without federal aid are organizing boycotts against Burroughs and considering lawsuits.
Source:
Independent Weekly
(NoCar Oversize AP 2 .I57 [volumes 13 - 23 on microfilm]), Vol. 6 Issue 7, Apr 7-20 1988,
p7, il
Periodical Website
Subject(s):
Record #:
24256
Author(s):
Abstract:
GlaxoSmithKline (GSK) is the world's eighth-largest pharmaceutical company and its U.S. headquarters are in Research Triangle Park. Despite high productivity, the company's profits have plummeted. This article surveys the profit plunge and layoffs while also discussing the future of the company and North Carolina's pharmaceutical industry as a whole.
Source:
Business North Carolina
(NoCar HF 5001 B8x), Vol. 35 Issue 9, September 2015,
p64-71, il, por
Periodical Website
Subject(s):
Full Text:
Record #:
36296
Author(s):
Abstract:
Source:
Subject(s):
Research and development partnership; College students; Nonprofit organizations; Urban development; Bacterial diseases; Medicine--Research; University of North Carolina at Greensboro; Pharmaceutical industry; North Carolina Agricultural and Technical State University; North Carolina Agricultural and Technical State University. Research; Greensboro
Record #:
27371
Author(s):
Abstract:
Chapel Hill resident David Jones recently testified before the U.S. Congress on the unethical practices in the pharmaceutical industry. Jones recounts stories from his career in the industry on how pharmaceutical companies boost profits through false demand and manipulate the market. These practices harm the consumer. Frustrated, Jones is now a lobbyist and has worked in NC politics on behalf of the consumer helping specifically with anti-discrimination legislation and privacy regulations for AIDS victims.
Source:
Independent Weekly
(NoCar Oversize AP 2 .I57 [volumes 13 - 23 on microfilm]), Vol. 9 Issue 4, Jan. 23-29 1991,
p8-9
Periodical Website
Record #:
22581
Author(s):
Abstract:
The Supreme Court ruled in FTC vs. Actavis, that courts are required to apply a rule of reason analysis in determining whether a reverse payment settlement violates antitrust laws. The reverse payment settlement, which is unique to pharmaceutical litigation, enables a patent-holder to maintain exclusivity in the relevant market and keep prices higher than they would or should be.
Source:
Subject(s):
Record #:
24218
Author(s):
Abstract:
The Merck and Co. deal, in which the company would build a vaccine plant in Durham, raises questions about where the state is going with economic incentives.
Source:
Business North Carolina
(NoCar HF 5001 B8x), Vol. 24 Issue 4, April 2004,
p28-35, il
Periodical Website
Record #:
32953
Author(s):
Abstract:
Glaxo Inc., one of North Carolina’s newest pharmaceutical companies, moved its headquarters from Great Britain to Research Triangle Park in August 1983. Glaxo is among the world’s top twenty pharmaceutical companies and produces more than 250 products. A state-of-the-art manufacturing facility is being constructed in Zebulon, and is designed to permit additional growth and expansion.
Source:
Subject(s):
Record #:
29178
Author(s):
Abstract:
Despite pinching of a contracting economy, North Carolina's health product industry is growing and expanding. The value of products and the amount of them being produced in and shipped from North Carolina has rapidly grown in the last decade, sometimes quadrupling the numbers seen in 1980.
Source:
Subject(s):
Record #:
3012
Author(s):
Abstract:
Calling on small-town doctors as a sales representative was the start of Robert Ingram's career in the pharmaceutical industry. Today he is president and CEO of Glaxo Wellcome's U.S. operations.
Source:
Record #:
29127
Author(s):
Abstract:
Prabhavathi Fernandes spent over three decades developing drugs for bacterial infections. On the brink of developing a treatment for pnemonia, Fernandes' Chapel Hill-based Cempra, Inc. was halted by federal regulators. Although Fernandes abruptly left the company, Cempra seeks to rebound.
Source:
Business North Carolina
(NoCar HF 5001 B8x), Vol. 37 Issue 8, August 2017,
p78-81, por
Periodical Website
Subject(s):
Record #:
32954
Author(s):
Abstract:
Ajinomoto U.S.A., Inc., located in Raleigh, began operations in 1982 as the only United States plant with the technical capabilities to produce a wide variety of pharmaceutical amino acids. The Japan-based company first developed monosodium glutamate (MSG), is a leader of research, and currently holds sixty-five percent of the world’s amino acids market. Before opening in Raleigh, all amino acids were imported from Japan.
Source:
Subject(s):
Record #:
32244
Author(s):
Abstract:
The author highlights some recent NC business news, including an acquisition of a pharmaceutical company by R.J. Reynolds Tobacco Company. In other news, the Mylecraft Manufacturing Company owned by Mrs. L. V. Myles was willed to the town of Rich Square upon her death.
Source:
Subject(s):
Full Text:
Record #:
36284
Author(s):
Abstract:
Community colleges, traditionally considered a second rate form of higher education, is increasingly making a first grade contribution to the state’s economy and work force. North Carolina’s fifty-eight community colleges are proving themselves an asset for fields such as biotechnology, welding, law enforcement, aviation, and manufacturing.
Source:
Subject(s):
Community colleges; Richmond Community College; Fayetteville Technical Community College--Research; Guilford Technical Community College; Meat industry and trade--Inspection; Pharmaceutical industry; Manufacturing industries; Employees--Training of; Aviation industry; Plastics industry and trade; Public safety programs; Law enforcement
Record #:
32949
Author(s):
Abstract:
Research and development (R&D) spending is the driving force of the pharmaceutical industry. Within North Carolina, resources include major research universities, the Research Triangle Institute, and the North Carolina Biotechnology Center located in the Research Triangle Park. Funding has enabled the development of new products and technologies, and profound impacts to the economy.
Source:
Subject(s):